[1]JournalofMedicinalChemistry,1994,vol.37,p.3108-3120
[1]Patent:US5374646,1994,A
[1]Patent:WO2018/96159,2018,A1.Locationinpatent:Paragraph0269;0270;0275;0276
[2]Patent:US2019/284179,2019,A1
[1]Patent:US2019/284179,2019,A1
144689-94-1
51605-32-4
86724-13-2
87326-25-8
97602-72-7
1080-79-1
50675-23-5 | (2,2-Dimethyltetrahydro-2H-pyran-4-yl)methanol | AA006WG9 | MFCD11054023
2417-42-7 | N-(3-Acetylphenyl)methanesulfonamide | AA006X3I | MFCD00664903
23985-60-6 | Hexanoic acid, 3-hydroxy-3-propyl- | AA006XLB | MFCD16749116
22383-85-3 | 2,3,4-Trimethoxy-6-methylbenzaldehyde | AA006Y2W | MFCD00016598
478832-21-2 | 4-Hydroxyazepane-1-carboxylic acid tert-butyl ester | AA006YL6 | MFCD07368610
218600-53-4 | Bardoxolone methyl | AA006YXA | MFCD11983137
22179-78-8 | 4-Fluorobenzamidoxime | AA006ZE8 | MFCD00216571
4946-64-9 | 1-(Furan-2-yl)-2,2-dimethylpropane-1,3-diol | AA006ZT6 | MFCD00720174
21650-54-4 | Diazene, bis(4-methylphenyl)-, (1E)- | AA0070BK | MFCD00048089
428855-17-8 | 1-[(Dibenzylamino)methyl]cyclopropan-1-ol | AA0070RE | MFCD07367843